Pfizer globally was undergoing a transformation and wanted an external perspective on their Go To Market model as it related to communications moving forward.


R3 conducted a number of stakeholder interviews across the global teams and those in the US, Europe, LATAM and Asia to understand the issues, and then draw some conclusions.  We also benchmarked Pfizer’s approach and fees against Best in Class FMCG and Pharma companies.


The pharma company now has a new level of clarity on the way forward, particularly as it relates to collaboration, communication, and the digital journey.